Pseudohypoparathyroidism type Ia and growth hormone deficiency. Growth hormone releasing hormone receptor defect?

Fotini Psychou1, Polyxeni Nicolaidou, Helen Georgouli

  • 1First Pediatric Department, Athens University Medical School, Aghia Sophia Children's Hospital, Athens, Greece.

Hormones (Athens, Greece)
|October 5, 2006
PubMed

Insights

This study details a boy with pseudohypoparathyroidism (PHP) and hypothyroidism who exhibited developmental delay and low growth hormone (GH). He showed no response to growth hormone-releasing hormone (GHRH), suggesting a potential GHRH receptor defect.

Area of Science:

  • Pediatric Endocrinology
  • Genetics
  • Metabolic Disorders

Background:

  • Pseudohypoparathyroidism (PHP) is a genetic disorder characterized by resistance to parathyroid hormone (PTH).
  • Albright's hereditary osteodystrophy (AHO) presents with characteristic physical features and biochemical abnormalities.
  • Combined endocrine deficiencies can occur in PHP, impacting growth and development.

Purpose of the Study:

  • To report a case of a boy with pseudohypoparathyroidism, hypothyroidism, and impaired growth hormone (GH) secretion.
  • To investigate the response to growth hormone-releasing hormone (GHRH) stimulation in this patient.
  • To explore potential receptor defects contributing to the observed endocrine dysfunction.

Main Methods:

  • Clinical presentation and physical examination for AHO features.
  • Biochemical assays for serum calcium, phosphate, PTH, thyroxine (T4), and thyroid-stimulating hormone (TSH).
  • Provocative testing for GH secretion using Glucagon, L-Dopa, and GHRH; Insulin-like Growth Factor I (IGFI) measurement before and after GH administration.

Main Results:

  • The patient displayed features of AHO and biochemical evidence of PHP (hypocalcemia, hyperphosphatemia, elevated PTH) with no response to PTH.
  • Hypothyroidism was confirmed with low T4 and high TSH.
  • Growth hormone (GH) levels remained low (<2.5 microg/L) after Glucagon/L-Dopa and GHRH stimulation (<0.2 microg/L), but responded to exogenous GH administration.

Conclusions:

  • The patient has confirmed PTH and TSH receptor defects.
  • The lack of GH response to GHRH suggests a possible GHRH receptor defect.
  • This case highlights the complex endocrine interplay and potential for multiple receptor defects in PHP.

Related Concept Videos

Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
The Parathyroid Glands00:59

The Parathyroid Glands

The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Major Hormones and Their Functions01:27

Major Hormones and Their Functions

Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...